Peer Reviewed
Clinical case review

Cardiovascular disease prevention in a newly diagnosed diabetic patient

John Amerena
Abstract
Is it time to start hypolipidaemic and antihypertensive treatment in this patient with newly diagnosed diabetes?
Key Points
    Case scenario

    My patient, Mark, is 53 years old and was diagnosed with type 2 diabetes six months ago. His blood sugar was not controlled well with diet and lifestyle modification, and he now takes metformin. He is not happy about needing medication.

    Despite his lifestyle changes, both his LDL-cholesterol level and systolic blood pressure are above recommended guidelines, but only just. He has an LDL-cholesterol level of 3.5 mmol/L, an HDL-cholesterol level of 1.2 mmol/L and a borderline blood pressure (measured on two separate occasions) of 135/75 mmHg; he has no proteinuria. Is it unquestionably time to start drug therapy to treat Mark’s dyslipidaemia and blood pressure, and should he be taking aspirin?

Get full access
Subscribe for full access to all articles
Buy this article

Single article purchases are temporarily unavailable due to site maintenance.

If you would like to purchase an article during this time, please email us at [email protected] with the article details and we'll assist you directly. We'll also let you know when online purchasing is available again.

Thank you for your patience and understanding.

Already a subscriber?